Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback